NICE Rejects Novartis, Roche in Draft Guidance


Original post, click here
Share this...
Tweet about this on TwitterShare on FacebookShare on LinkedInEmail this to someoneShare on Google+Share on RedditPin on Pinterest

In a down day for drugmakers Novartis and Roche, the National Institute for Health and Care Excellence (NICE) turned down drugs from both companies in a draft guidance published Tuesday.

NICE opted not to support drugs from both companies for regular use in the National Health Service.

Click here to read a full report on the Pharma Letter. (Paid subscription required)